Cargando…
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Neutrophils have recently gained recognition for their potential in the fight against cancer. Neutrophil plasticity between the N1 anti-tumor and N2 pro-tumor subtypes is now apparent, as is the ability to polarize these individual subtypes by interventions such as intratumoral injection of various...
Autores principales: | Ralph, Stephen John, Reynolds, Maxwell J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446783/ https://www.ncbi.nlm.nih.gov/pubmed/36066649 http://dx.doi.org/10.1007/s00262-022-03248-8 |
Ejemplares similares
-
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells
por: Raychaudhuri, Deblina, et al.
Publicado: (2019) -
Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST
por: Goldmacher, Gregory V., et al.
Publicado: (2020) -
Intratumoral Immunotherapy—Update 2019
por: Hamid, Omid, et al.
Publicado: (2019) -
Trial watch: intratumoral immunotherapy
por: Humeau, Juliette, et al.
Publicado: (2021) -
Immunotherapeutic Agents for Intratumoral Immunotherapy
por: Shyr, Chih-Rong, et al.
Publicado: (2023)